A Hierarchical Genotyping Framework Using DNA Melting Temperatures Applied to Adenovirus Species Typing.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
13 May 2022
Historique:
received: 02 04 2022
revised: 06 05 2022
accepted: 10 05 2022
entrez: 28 5 2022
pubmed: 29 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

Known genetic variation, in conjunction with post-PCR melting curve analysis, can be leveraged to provide increased taxonomic detail for pathogen identification in commercial molecular diagnostic tests. Increased taxonomic detail may be used by clinicians and public health decision-makers to observe circulation patterns, monitor for outbreaks, and inform testing practices. We propose a method for expanding the taxonomic resolution of PCR diagnostic systems by incorporating a priori knowledge of assay design and sequence information into a genotyping classification model. For multiplexed PCR systems, this framework is generalized to incorporate information from multiple assays to increase classification accuracy. An illustrative hierarchical classification model for human adenovirus (HAdV) species was developed and demonstrated ~95% cross-validated accuracy on a labeled dataset. The model was then applied to a near-real-time surveillance dataset in which deidentified adenovirus detected patient test data from 2018 through 2021 were classified into one of six adenovirus species. These results show a marked change in both the predicted prevalence for HAdV and the species makeup with the onset of the COVID-19 pandemic. HAdV-B decreased from a pre-pandemic predicted prevalence of up to 40% to less than 5% in 2021, while HAdV-A and HAdV-F species both increased in predicted prevalence.

Identifiants

pubmed: 35628251
pii: ijms23105441
doi: 10.3390/ijms23105441
pmc: PMC9141461
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Infect Control Hosp Epidemiol. 2010 Jul;31(7):755-7
pubmed: 20509762
J Biol Chem. 1979 Jun 10;254(11):4876-83
pubmed: 220264
J Clin Microbiol. 2015 Feb;53(2):746-9
pubmed: 25520444
JMIR Public Health Surveill. 2018 Jul 06;4(3):e59
pubmed: 29980501
Emerg Infect Dis. 2016 Jun;22(6):1044-51
pubmed: 27191834
Clin Infect Dis. 2012 May;54(9):1275-86
pubmed: 22412058
Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1460-5
pubmed: 9465037
PLoS One. 2011;6(10):e26047
pubmed: 22039434
J Clin Microbiol. 2000 Nov;38(11):4114-20
pubmed: 11060077
Ann Am Thorac Soc. 2015 May;12(5):775-81
pubmed: 25714788
Open Forum Infect Dis. 2021 Mar 17;8(7):ofab133
pubmed: 34322558
Sci Rep. 2014 Dec 08;4:7365
pubmed: 25482188
Front Microbiol. 2018 Sep 11;9:2178
pubmed: 30254627
Emerg Infect Dis. 1999 May-Jun;5(3):379-85
pubmed: 10341174
J Med Virol. 2018 May;90(5):873-880
pubmed: 29350418
Mol Med Rep. 2018 Sep;18(3):2889-2897
pubmed: 30015894
Clin Microbiol Infect. 2018 Apr;24(4):355-360
pubmed: 29117578
Methods. 2001 Dec;25(4):430-42
pubmed: 11846612
J Clin Microbiol. 1984 Sep;20(3):365-72
pubmed: 6092424
J Clin Virol. 2021 Jan;134:104716
pubmed: 33360858
Trends Microbiol. 2011 Jan;19(1):24-32
pubmed: 21055948
Clin Microbiol Rev. 2014 Jul;27(3):441-62
pubmed: 24982316
Eur J Microbiol Immunol (Bp). 2014 Mar;4(1):26-33
pubmed: 24678403
Anal Biochem. 1997 Feb 15;245(2):154-60
pubmed: 9056205
J Clin Virol. 2020 Mar;124:104262
pubmed: 32007841
Semin Respir Crit Care Med. 2016 Aug;37(4):586-602
pubmed: 27486739
Lancet Infect Dis. 2016 May;16(5):e64-e75
pubmed: 26929196

Auteurs

Ben Galvin (B)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Jay Jones (J)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Michaela Powell (M)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Katherine Olin (K)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Matthew Jones (M)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Thomas Robbins (T)

bioMérieux Inc., Salt Lake City, UT 84108, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH